Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sagent Pharmaceuticals
Schaumburg, Illinois, USAsagentpharma.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Sagent has a broad commercial portfolio of over fifty injectable products across multiple therapeutic areas in the U.S. market. The company focuses on hospital and acute-care settings with an emphasis on safety through innovative packaging.[1][2][7] No proprietary clinical-stage assets; all marketed as generics or via partnerships.
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- Small molecules (injectable generics)Biologics (limited; focus on injectables)
- Industry
- Biotech
02
Partnerships
Strides Arcolab—joint development/manufacturing partnership for U.S. injectable market [6]
Beyond the preview
Go deeper on Sagent Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sagent Pharmaceuticals.